Észak-Pesti Centrumkórház-Honvédkórház

Budapest 1134

1 studies enrolling now · 7 studies all time

What they study most

Acute Myocardial Infarction, Castration-resistant Prostate Cancer, Colorectal Cancer, Congestive Heart Failure, Cutaneous Squamous Cell Carcinoma, Heart Failure, Hepatocellular Carcinoma, Moderate Hemophilia A, Moderately to Severely Active Crohns Disease, Moderately to Severely Active Ulcerative Colitis, Non-Small Cell Lung Cancer, Ovarian Cancer

Studies at this site

• A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (Also Known as RO7790121) in Participants With Moderately to Severely Active Ulcerative Colitis — Recruiting now
• A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease — Recruiting now
• A Study to Evaluate Overall Health, Physical Activity, and Joint Outcomes in Participants With Severe or Moderate Hemophilia A Without Factor VIII Inhibitors on Emicizumab Prophylaxis — Running, not enrolling
• A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Heart Failure and Inflammation — Running, not enrolling
• Phosphatase Inhibition by Intracoronary Gene Therapy in Subjects With Non-Ischemic NYHA Class III Heart Failure — Running, not enrolling
• A Study of SOT101 in Combination With Pembrolizumab to Evaluate the Efficacy and Safety in Patients With Selected Advanced Solid Tumors — Stopped early
• Evaluation in STEMI Patients Using FDY-5301 — Completed